Compare NRG Energy Inc (NRG) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NRG Energy Inc vs Viatris Inc — how do they compare? NRG Energy Inc trades at $116.71 (market cap $25.15B), while Viatris Inc trades at $16.45 (market cap $19.09B). The key difference: NRG Energy Inc is the larger of the two by market cap, and Viatris Inc pays the higher dividend (2.89%). Which is the better fit depends on your goals.
| NRG | VTRS | |
|---|---|---|
Market Cap | $25.15B | $19.09B |
Sector | Utilities | Health |
52-Week High | $184.03 | $17.86 |
52-Week Low | $109.51 | $9.49 |
Enterprise Value | $49.10B | $31.21B |
Dividend Yield | 1.59% | 2.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NRG Energy trades at $119.64, up 0.52% on the day, with a bullish technical signal and key support at $118. Recent Q2 2026 earnings missed estimates, but revenue grew 11% year-over-year. The company is pursuing growth via a 1.2 GW Texas data center power project and reaffirmed 2026 guidance, while analyst consensus remains strongly positive with a $201.29 price target.
The outlook is supported by strategic investments in data center demand and shareholder returns, but risks include rising interest costs, high leverage, and execution challenges. The stock offers significant upside to analyst targets if growth initiatives deliver, though near-term volatility may persist amid earnings misses and macroeconomic pressures.
Viatris (VTRS) trades at $16.61, down 1.6% on the day, with a bullish technical signal but mixed moving averages. The company reported Q2 2026 EPS of $0.69, beating estimates, and revenue growth of 5% year-over-year. Despite negative net income margins, strong cash flow generation supports dividends and buybacks. Recent news highlights pipeline progress and a higher 2026 outlook.
Outlook: Viatris shows operational strength with consistent earnings beats and cash flow, but high P/E and negative profitability pose risks. Investment opportunity lies in deleveraging and pipeline advancements, while headwinds include generic drug pricing pressure and regulatory uncertainty. Analyst sentiment is mixed with a hold-heavy consensus.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
